
An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, according to a new study.

Northwestern Medicine investigators have discovered that a particular enzyme is essential for regulating cancer cell survival and metastasis under cellular stress, according to a recent study.

Investigators discovered that the loss of the gene SLIT2 in circulating tumor cells regulates metastasis of prostate cancer tumors, according to a Northwestern Medicine study.

A new grant will fund the hiring of 15 new tenure-track faculty, along with tactics to ensure the success of faculty members from underrepresented populations.

A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.

Investigators have developed a new imaging technique that increases the detection and identification of proteoforms by four-fold when compared to current methods.

Investigators have identified distinct epigenetic pathways in African American and European American patients diagnosed with multiple myeloma, according to a Northwestern Medicine study.

A Northwestern Medicine study has identified a molecular mechanism that helps regulate the progression of castration-resistant prostate cancer.

After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.

A change in function in a mitochondrial protein is associated with gene expression that may promote the development of cancer, according to a recent Northwestern Medicine Study.